ArticlemedRxiv : the preprint server for health sciences2021

Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial.

Susan M Bueno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.